Aclidinium bromide/Formoterol fumarate (Fixed-dose Combination 1)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aclidinium bromide/Formoterol fumarate (Fixed-dose Combination 1), covering 2017-04-21 to 2017-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]